Digital Edition

SYS-CON.TV
Oracle Focuses on Life Sciences at OpenWorldLeading Software Solutions Provider Helps Biosciences, Genomic, Pharmaceutical Firms
Oracle Focuses on Life Sciences at OpenWorldLeading Software Solutions Provider Helps Biosciences, Genomic, Pharmaceutical Firms

(San Francisco) –Speaking at Oracle OpenWorld's inaugural Life Sciences Day on December 4, Lawrence J. Ellison, chairman and CEO of Oracle Corporation, extolled the life sciences industry for engineering quantum leaps in scientific knowledge and drug therapy, and reaffirmed Oracle's long-standing commitment to facilitate the valuable research and discovery efforts of biosciences, genomic and pharmaceutical companies.

Working with leaders in the life sciences field for more than a decade, Oracle has developed an integrated, end-to-end information-management solution to meet needs of this rapidly growing industry. With more than 65 per cent of life sciences companies running Oracle technology -- including Fortune 500's top 10 pharmaceutical/biotech companies -- Oracle is uniquely positioned to support the massively data-intensive lifecycles of new products, and enable these companies to run their businesses more efficiently and cost-effectively.

On Life Sciences Day at Oracle’s OpenWorld, Simmons and such industry leaders as Dr. J. Craig Venter, president and chief scientific officer of Celera Genomics; J. Guy Kraines, vice president, corporate IT, Genentech, Inc.; Brian Atwood, managing director, Versant Ventures; and William Blake, vice president, high-performance technical computing, at Compaq Computer, discussed the technology challenges at each critical phase of product development -- discovery, development, manufacturing, sales and marketing, and regulatory compliance -- and how Oracle solutions help meet them. Oracle's Pharmaceutical Applications enable companies reduce product time-to-market and clinical development costs. Oracle Process Manufacturing provides life sciences companies with a strategic, secure, Internet-based, supply-chain management solution, including integrated recipe management, cost management, logistics, inventory management, regulatory compliance and quality management. Oracle Grants helps companies manage funding, and Oracle Clinical helps companies track preclinical and clinical stages of product development.

Oracle also has a philanthropic interest in biotechnology: in 1999, it donated more than $800,000 in software and technical support services to the bioinformatics program at The Hospital for Sick Children in Toronto. The gift has been used to restructure the human genome database (GBD), a foremost source of information on human genes.

About Java News Desk
JDJ News Desk monitors the world of Java to present IT professionals with updates on technology advances, business trends, new products and standards in the Java and i-technology space.

In order to post a comment you need to be registered and logged in.

Register | Sign-in

Reader Feedback: Page 1 of 1

I am not aware of the "end-to-end information-management solution" Oracle offers for biotechnology.
Please provide me with more information.

Ed Lees
Assoc. Director
Research Information Systems
Amgen, Inc.




ADS BY GOOGLE
Subscribe to the World's Most Powerful Newsletters

ADS BY GOOGLE

The explosion of new web/cloud/IoT-based applications and the data they generate are transforming ou...
CI/CD is conceptually straightforward, yet often technically intricate to implement since it require...
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple ...
Enterprises are striving to become digital businesses for differentiated innovation and customer-cen...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As au...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't com...
The now mainstream platform changes stemming from the first Internet boom brought many changes but d...
DXWorldEXPO LLC announced today that All in Mobile, a mobile app development company from Poland, wi...
DXWorldEXPO LLC announced today that Ed Featherston has been named the "Tech Chair" of "FinTechEXPO ...
Chris Matthieu is the President & CEO of Computes, inc. He brings 30 years of experience in developm...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: D...
Andi Mann, Chief Technology Advocate at Splunk, is an accomplished digital business executive with e...
In this presentation, you will learn first hand what works and what doesn't while architecting and d...
The Internet of Things is clearly many things: data collection and analytics, wearables, Smart Grids...
To Really Work for Enterprises, MultiCloud Adoption Requires Far Better and Inclusive Cloud Monitori...
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use ...
If your cloud deployment is on AWS with predictable workloads, Reserved Instances (RIs) can provide ...
Disruption, Innovation, Artificial Intelligence and Machine Learning, Leadership and Management hear...
We build IoT infrastructure products - when you have to integrate different devices, different syste...
Consumer-driven contracts are an essential part of a mature microservice testing portfolio enabling ...